http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14072772

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 114
issn 1387-2877
1875-8908
issueIdentifier 1
pageRange 1-114
publicationName Journal of Alzheimer's disease : JAD
startingPage 1
bibliographicCitation Froestl W, Pfeifer A, Muhs A. Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs. J Alzheimers Dis. 2013;34(1):1–114. doi: 10.3233/jad-121729. PMID: 23186990.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_960d396af8a4222c4c812c8105f2060e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f34c41cc98e44b2a5d9147c0bd314656
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d13709d1e88dc741f5e2aabd2dd5205
date 2013-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/23186990
https://doi.org/10.3233/jad-121729
isPartOf https://portal.issn.org/resource/ISSN/1875-8908
https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs
discusses http://id.nlm.nih.gov/mesh/M0028009
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4843
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6997
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9168
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852

Total number of triples: 28.